HDAC1 is a target of miR-449 [12], a recent study showed that in lung cancer, miR-449 has a synergistic effect on growth arrest with HDAC inhibitor [15], providing new information about combination therapy with miRNA and c-Met inhibitors. This evidence concerns the gene MET and lung cancer.